Want to join the conversation?
$FB 2Q15 Q&A: On a question asked by Anmuth of JPMorgan about Oculus effecting cost structure, David answered that it’s premature to give guidance in 2016. FB is still early with Oculus, haven’t announced any specific shipment volume plans. FB is investing on the R&D side on Oculus in 2015 and is factored into expense guidance for this year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?